850754.fig.002a
(a)
850754.fig.002b
(b)
850754.fig.002c
(c)
850754.fig.002d
(d)
850754.fig.002e
(e)
850754.fig.002f
(f)
850754.fig.002g
(g)
Figure 2: System behavior obtained with the use of different vaccination protocols: untreated (blue dashed line), activated OT1 CTLs (red dot-dashed lines), Anti-CD137 monoclonal antibodies (green dotted lines), and activated OT1 CTLs + Anti-CD137 monoclonal antibodies (black solid lines). From left to right, top to bottom: melanoma cells ( ), tumor antigens ( ), activated OT1 CTLs in the skin ( ), naïve CTLs ( ), antibodies in the skin ( ), antibodies in the injection point ( , and activated OT1 CTLs in the injection point ( ).